Not Signed In - FDA Approves Pramipexole For The Treatment Of Moderate-to-severe Primary Restless Legs Syndrome
Mon, 13 Nov 2006 08:00 AM EST
... Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS). [click link for full article] ...
Related Topics
- Restless Legs Syndrome
- Pramipexole
- Restless Legs Syndro
- Primary
- Pulmonary Hypertension
- Primary Care
- Cervical Dysplasia
- Carpal Tunnel Syndrome
- Immune Deficiency
- Restless Leg Syndrome
- Tourette Syndrome
- Severe Acute Respiratory Syndrome (SARS)
- Lymphedema
- Syndrome X
- Asperger's Syndrome
- Down Syndrome
- Marfan Syndrome
- Metabolic Syndrome
- Williams Syndrome
- Asperger Syndrome
email this page
print this page
bookmark this page
feedback on this page
